Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Zimmer-Galler

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
American Journal of Ophthalmology|April 25, 2015
Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) StudyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Ophthalmology|May 1, 2016
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 4, 2005
Telehealth practice recommendations for diabetic retinopathyJerry Cavallerano, Mary G Lawrence, Ingrid Zimmer-Galler, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
American Journal of Ophthalmology|April 25, 2015
Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) StudyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Ophthalmology|May 1, 2016
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 4, 2005
Telehealth practice recommendations for diabetic retinopathyJerry Cavallerano, Mary G Lawrence, Ingrid Zimmer-Galler, et al.
Pageof 3